Gillespie SL, Hanrahan TP, Rockey DC, Majumdar A, Hayes PC. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023;57(5):454–463. https://doi.org/10.1111/apt.17380

Article  PubMed  Google Scholar 

D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–231. https://doi.org/10.1016/j.jhep.2005.10.013

Article  PubMed  Google Scholar 

Engelmann C, Claria J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75:549–566. https://doi.org/10.1016/j.jhep.2021.01.002

Article  CAS  Google Scholar 

Kaplan DE, Ripoll C, Thiele M, et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology. 2023;79(5):1180–1211. https://doi.org/10.1097/HEP.0000000000000647

Article  PubMed  Google Scholar 

Villanueva C, Torres F, Sarin SK, et al. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol. 2022;77(4):1014–1025. https://doi.org/10.1016/j.jhep.2022.05.021

Article  PubMed  CAS  Google Scholar 

Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. Cochrane Database Syst Rev. 2018;10(10):CD011510. https://doi.org/10.1002/14651858.CD011510.pub2

Article  PubMed  Google Scholar 

Yang J, Ge K, Chen L, Yang JL. The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective beta-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis. Eur J Gastroenterol Hepatol. 2019;31(12):1518–1526. https://doi.org/10.1097/MEG.0000000000001442

Article  PubMed  Google Scholar 

Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. Oct 3 2019;10(10):000142. https://doi.org/10.1002/14651858.ED000142

Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898

Article  PubMed  Google Scholar 

Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7–8):932–944. https://doi.org/10.1002/sim.3767

Article  PubMed  CAS  Google Scholar 

Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80–97. https://doi.org/10.1002/jrsm.1037

Article  PubMed  Google Scholar 

Nikolakopoulou A, Higgins JPT, Papakonstantinou T, et al. CINeMA: An approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4): e1003082. https://doi.org/10.1371/journal.pmed.1003082

Article  PubMed  PubMed Central  Google Scholar 

Ansari TA, Kadir S, Dahar BA, Baig MA, Amin MJ, Shaikh SA. The Effectiveness of Carvedilol Versus Propranol in Preventing Recurrence of Bleeding in Cirrhotic Patients: A Comparative Study. Pakistan Journal of Medical and Health Sciences. 2021;15(3):596–598

Google Scholar 

Chen WC, Hsin IF, Chen PH, et al. Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2019;17(11):2356–2363. https://doi.org/10.1016/j.cgh.2019.02.021

Article  PubMed  CAS  Google Scholar 

Gupta V, Rawat R, Shalimar, Saraya A. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT. Hepatol Int. Mar 2017;11(2):181–187. https://doi.org/10.1007/s12072-016-9765-y

Lo GH, Chen WC, Wang HM, Yu HC. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding. J Gastroenterol Hepatol. 2012;27(11):1681–1687. https://doi.org/10.1111/j.1440-1746.2012.07244.x

Article  PubMed  CAS  Google Scholar 

Premkumar M, Rangegowda D, Vyas T, et al. Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis. J Clin Gastroenterol. 2020;54(6):561–568. https://doi.org/10.1097/MCG.0000000000001219

Article  PubMed  CAS  Google Scholar 

Sharma S, Agarwal S, Gunjan D, et al. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. J Clin Exp Hepatol May-Jun. 2021;11(3):343–353. https://doi.org/10.1016/j.jceh.2020.08.009

Article  CAS  Google Scholar 

Stanley AJ, Dickson S, Hayes PC, et al. Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. J Hepatol. 2014;61(5):1014–1019. https://doi.org/10.1016/j.jhep.2014.06.015

Article  PubMed  CAS  Google Scholar 

Abraldes JG, Villanueva C, Aracil C, et al. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology. 2016;150(5):1160–1170. https://doi.org/10.1053/j.gastro.2016.01.004

Article  PubMed  CAS  Google Scholar 

Acharya SK, Dasarathy S, Saksena S, Pande JN. A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol. 1993;19(2):291–300. https://doi.org/10.1016/s0168-8278(05)80585-9

Article  PubMed  CAS  Google Scholar 

Ahmad I, Khan AA, Alam A, Butt AK, Shafqat F, Sarwar S. Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding. J Coll Physicians Surg Pak. 2009;19(5):283–286

PubMed  Google Scholar 

Avgerinos A, Rekoumis G, Klonis C, et al. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial J Hepatol. 1993;19(2):301–311. https://doi.org/10.1016/s0168-8278(05)80586-0

Article  PubMed  CAS  Google Scholar 

Burroughs AK, Jenkins WJ, Sherlock S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1983;309(25):1539–1542. https://doi.org/10.1056/NEJM198312223092502

Article  PubMed  CAS  Google Scholar 

Dasarathy S, Dwivedi M, Bhargava DK, Sundaram KR, Ramachandran K. A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients. Hepatology. 1992;16(1):89–94. https://doi.org/10.1002/hep.1840160116

Article  PubMed  CAS  Google Scholar 

de la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology. 2005;41(3):572–578. https://doi.org/10.1002/hep.20584

Article  PubMed  CAS  Google Scholar 

Escorsell A, Banares R, Garcia-Pagan JC, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology. 2002;35(2):385–392. https://doi.org/10.1053/jhep.2002.30418

Article  PubMed  Google Scholar 

Evrard S, Dumonceau JM, Delhaye M, Golstein P, Deviere J, Le Moine O. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy. Sep 2003;35(9):729–35. https://doi.org/10.1055/s-2003-41581

Fleig WE, Stange EF, Hunecke R, et al. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology Mar-Apr. 1987;7(2):355–361. https://doi.org/10.1002/hep.1840070224

Article  CAS  Google Scholar 

Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–2379. https://doi.org/10.1056/NEJMoa0910102

Article  PubMed  CAS  Google Scholar 

Garcia-Pagan JC, Villanueva C, Albillos A, et al. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. Gut. 2009;58(8):1144–1150. https://doi.org/10.1136/gut.2008.171207

Article  PubMed  CAS  Google Scholar 

Garden OJ, Mills PR, Birnie GG, Murray GD, Carter DC. Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial Gastroenterology. 1990;98(1):185–190.